Baculovirus-Free SARS-CoV-2 Virus-like Particle Production in Insect Cells for Rapid Neutralization Assessment.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
20 09 2022
Historique:
received: 29 08 2022
revised: 16 09 2022
accepted: 18 09 2022
entrez: 27 10 2022
pubmed: 28 10 2022
medline: 29 10 2022
Statut: epublish

Résumé

Virus-like particles (VLPs) resemble authentic virus while not containing any genomic information. Here, we present a fast and powerful method for the production of SARS-CoV-2 VLP in insect cells and the application of these VLPs to evaluate the inhibition capacity of monoclonal antibodies and sera of vaccinated donors. Our method avoids the baculovirus-based approaches commonly used in insect cells by employing direct plasmid transfection to co-express SARS-CoV-2 envelope, membrane, and spike protein that self-assemble into VLPs. After optimization of the expression plasmids and vector ratios, VLPs with an ~145 nm diameter and the typical "Corona" aura were obtained, as confirmed by nanoparticle tracking analysis (NTA) and transmission electron microscopy (TEM). Fusion of the membrane protein to GFP allowed direct quantification of binding inhibition to angiotensin II-converting enzyme 2 (ACE2) on cells by therapeutic antibody candidates or sera from vaccinated individuals. Neither VLP purification nor fluorescent labeling by secondary antibodies are required to perform these flow cytometric assays.

Identifiants

pubmed: 36298643
pii: v14102087
doi: 10.3390/v14102087
pmc: PMC9606917
pii:
doi:

Substances chimiques

Angiotensin-Converting Enzyme 2 EC 3.4.17.23
Spike Glycoprotein, Coronavirus 0
Angiotensin II 11128-99-7
Antibodies, Monoclonal 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Sci Rep. 2021 Feb 10;11(1):3515
pubmed: 33568700
Cell Rep. 2021 Jul 27;36(4):109433
pubmed: 34273271
PLoS One. 2013 Jul 17;8(7):e68674
pubmed: 23874717
Adv Virus Res. 2006;66:193-292
pubmed: 16877062
Heliyon. 2021 Oct;7(10):e08124
pubmed: 34632131
N Biotechnol. 2017 Oct 25;39(Pt B):174-180
pubmed: 28778817
Emerg Microbes Infect. 2020 Dec;9(1):2105-2113
pubmed: 32893735
Sci Rep. 2022 Jan 19;12(1):1005
pubmed: 35046461
Virology. 2015 Apr;478:75-85
pubmed: 25726972
Protein Expr Purif. 2013 Aug;90(2):104-16
pubmed: 23742819
Science. 2020 Mar 13;367(6483):1260-1263
pubmed: 32075877
Sci Rep. 2020 Dec 14;10(1):21877
pubmed: 33318562
J Biotechnol. 2014 Feb 10;171:61-70
pubmed: 24333123
Cells. 2021 Apr 09;10(4):
pubmed: 33918600
Biotechnol J. 2015 May;10(5):702-14
pubmed: 25800821
Front Bioeng Biotechnol. 2020 Jul 30;8:862
pubmed: 32850726
Biotechnol Bioeng. 2016 Sep;113(9):1975-83
pubmed: 26913471
Front Microbiol. 2022 Jan 03;12:790121
pubmed: 35046918
Emerg Microbes Infect. 2021 Dec;10(1):894-904
pubmed: 33929934
Nat Commun. 2021 Jul 30;12(1):4629
pubmed: 34330917
Viruses. 2022 Apr 27;14(5):
pubmed: 35632656
Bio Protoc. 2018 Jul 20;8(14):
pubmed: 30073182
Sci Rep. 2020 Dec 7;10(1):21393
pubmed: 33288836
Nat Commun. 2021 Mar 11;12(1):1577
pubmed: 33707427
Semin Immunol. 2017 Dec;34:123-132
pubmed: 28887001
Nat Microbiol. 2020 Apr;5(4):562-569
pubmed: 32094589
BMC Med. 2022 Mar 3;20(1):102
pubmed: 35236358
J Biol Chem. 2021 Jan-Jun;296:100111
pubmed: 33229438
Appl Microbiol Biotechnol. 2018 Dec;102(24):10495-10510
pubmed: 30317441
BMC Biotechnol. 2007 Jul 04;7:39
pubmed: 17610729
Mol Biotechnol. 2013 Jan;53(1):92-107
pubmed: 23001867
Emerg Microbes Infect. 2020 Dec;9(1):680-686
pubmed: 32207377
Vaccines (Basel). 2021 May 26;9(6):
pubmed: 34073159
PLoS One. 2021 Mar 10;16(3):e0248348
pubmed: 33690649
Nat Commun. 2020 Mar 27;11(1):1620
pubmed: 32221306
Gene. 2001 May 30;270(1-2):61-8
pubmed: 11404003
PLoS One. 2015 Aug 11;10(8):e0132898
pubmed: 26263512
J Biotechnol. 2015 Dec 20;216:67-75
pubmed: 26476358
Microbiol Immunol. 2022 Jan;66(1):15-23
pubmed: 34561887
Front Microbiol. 2021 Oct 20;12:732998
pubmed: 34745036
Methods Mol Biol. 2015;1282:1-23
pubmed: 25720466

Auteurs

Marcel Jaron (M)

Department of Biotechnology, Technische Universität Braunschweig, Spielmannstraße 7, 38106 Braunschweig, Germany.

Michael Lehky (M)

Recombinant Protein Expression Platform, Helmholtz Centre for Infection Research, Inhoffenstraße 7, 38124 Braunschweig, Germany.

Marta Zarà (M)

Unit of Brain-Heart Axis, IRCCS Monzino Cardiology Center, Via C. Parea 4, 20138 Milano, Italy.

Chris Nicole Zaydowicz (CN)

Division of Cellular and Molecular Neurobiology, Zoological Institute, Technische Universität Braunschweig, Spielmannstraße 7, 38106 Braunschweig, Germany.

Aidin Lak (A)

Institute for Electrical Measurement Science and Fundamental Electrical Engineering, Technische Universität Braunschweig, Hans-Sommer-Straße 66, 38106 Braunschweig, Germany.

Rico Ballmann (R)

Department of Biotechnology, Technische Universität Braunschweig, Spielmannstraße 7, 38106 Braunschweig, Germany.

Philip Alexander Heine (PA)

Department of Biotechnology, Technische Universität Braunschweig, Spielmannstraße 7, 38106 Braunschweig, Germany.

Esther Veronika Wenzel (EV)

Abcalis GmbH, Inhoffenstraße 7, 38124 Braunschweig, Germany.

Kai-Thomas Schneider (KT)

Department of Biotechnology, Technische Universität Braunschweig, Spielmannstraße 7, 38106 Braunschweig, Germany.

Federico Bertoglio (F)

Department of Biotechnology, Technische Universität Braunschweig, Spielmannstraße 7, 38106 Braunschweig, Germany.

Susanne Kempter (S)

Department of Physics, Ludwig-Maximilians-Universität, Geschwister-Scholl-Platz 1, 80539 München, Germany.

Reinhard Wolfgang Köster (RW)

Division of Cellular and Molecular Neurobiology, Zoological Institute, Technische Universität Braunschweig, Spielmannstraße 7, 38106 Braunschweig, Germany.

Silvia Stella Barbieri (SS)

Unit of Brain-Heart Axis, IRCCS Monzino Cardiology Center, Via C. Parea 4, 20138 Milano, Italy.

Joop van den Heuvel (J)

Recombinant Protein Expression Platform, Helmholtz Centre for Infection Research, Inhoffenstraße 7, 38124 Braunschweig, Germany.

Michael Hust (M)

Department of Biotechnology, Technische Universität Braunschweig, Spielmannstraße 7, 38106 Braunschweig, Germany.

Stefan Dübel (S)

Department of Biotechnology, Technische Universität Braunschweig, Spielmannstraße 7, 38106 Braunschweig, Germany.

Maren Schubert (M)

Department of Biotechnology, Technische Universität Braunschweig, Spielmannstraße 7, 38106 Braunschweig, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH